• Focus
  • Criteria
  • Team
  • Investments
  • Resources
  • News
  • Contact
 
Logo
  • Focus
  • Criteria
  • Team
  • Investments
  • Resources
  • News
  • Contact

Oculogica mentioned in February 19, 2019 issue of JAMA

by Sofia Fund | Feb 19, 2019 | Portfolio Company News

Oculogica is the first highlight of the JAMA news section in this week’s issue: https://jamanetwork.com/journals/jama/fullarticle/2725217

Download PDF

Tags: Oculogica

Older post: Cognition Therapeutics Announces Publication of Complete Results from Phase 1 Clinical Trial of Elayta™
Newer post: Cognition Therapeutics Receives European Patent Covering its Alzheimer’s Disease Candidate, Elayta™

News Categories

  • Sofia Fund Blog (7)
  • Sofia Fund News (29)
  • Sofia Fund Investments (7)
  • Sofia Fund Exits (3)
  • Portfolio Company News (39)
  • Angel and VC Investment News (4)
  • Women Entrepreneurship (1)
  • Clinician Nexus
  • CogRx
  • ExplORer
  • Joylux
  • Kenzen
  • Kidizen
  • Landit
  • Oculogica
  • Rebiotix
  • StormSensor
  • TiLT
  • Vixar

© Copyright 2025 Sofia Fund. All Rights Reserved.   |   Privacy Policy